Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Myelin and Lymphocyte-Associated Proteolipid Proteins × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Bowen's Disease 1

Interventions

pembrolizumab 1111 Specimen Handling 743 Carboplatin 740 Cyclophosphamide 715 Magnetic Resonance Spectroscopy 694 Cisplatin 635 Nivolumab 608 Paclitaxel 556 Radiotherapy 498 Gemcitabine 488 Biopsy 456 Bevacizumab 410 Dexamethasone 393 fludarabine 348 Docetaxel 346 venetoclax 339 Fluorouracil 323 Oxaliplatin 323 atezolizumab 317 Capecitabine 315 Rituximab 312 durvalumab 296 Doxorubicin 281 Pemetrexed 279 Radiosurgery 273 Drug Therapy 270 Ipilimumab 270 Standard of Care 260 Radiation 252 Lenalidomide 251

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03909646 2025-05-06

BOWTIE

Maastricht University Medical Center

Phase 4 Completed

Bowen's Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡